Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, F4-105 PO Box 22700, 1100 DE Amsterdam, The Netherlands.
Ann Rheum Dis. 2012 May;71(5):638-41. doi: 10.1136/annrheumdis-2011-200990. Epub 2012 Mar 2.
The Study Group for Risk Factors for Rheumatoid Arthritis was established by the EULAR Standing Committee on Investigative Rheumatology to facilitate research into the preclinical and earliest clinically apparent phases of rheumatoid arthritis (RA). This report describes the recommendation for terminology to be used to define specific subgroups during different phases of disease, and defines the priorities for research in this area. Terminology was discussed by way of a three-stage structured process: A provisional list of descriptors for each of the possible phases preceding the diagnosis of RA were circulated to members of the study group for review and feedback. Anonymised comments from the members on this list were fed back to participants before a 2-day meeting. 18 participants met to discuss these data, agree terminologies and prioritise important research questions. The study group recommended that, in prospective studies, individuals without RA are described as having: genetic risk factors for RA; environmental risk factors for RA; systemic autoimmunity associated with RA; symptoms without clinical arthritis; unclassified arthritis; which may be used in a combinatorial manner. It was recommended that the prefix 'pre-RA with:' could be used before any/any combination of the five points above but only to describe retrospectively a phase that an individual had progressed through once it was known that they have developed RA. An approach to dating disease onset was recommended. In addition, important areas for research were proposed, including research of other tissues in which an adaptive immune response may be initiated, and the identification of additional risk factors and biomarkers for the development of RA, its progression and the development of extra-articular features. These recommendations provide guidance on approaches to describe phases before the development of RA that will facilitate communication between researchers and comparisons between studies. A number of research questions have been defined, requiring new cohorts to be established and new techniques to be developed to image and collect material from different sites.
类风湿关节炎风险因素研究组由 EULAR 调查性风湿病学常务委员会设立,旨在促进类风湿关节炎(RA)临床前和最早临床可见阶段的研究。本报告描述了用于定义疾病不同阶段特定亚组的术语建议,并定义了该领域研究的优先事项。术语是通过三阶段结构化过程进行讨论的:RA 诊断前各可能阶段的描述符临时清单分发给研究组成员审查和反馈。匿名的成员意见反馈给参与者,然后进行为期两天的会议。18 名参与者开会讨论这些数据,商定术语并确定重要的研究问题。研究组建议,在前瞻性研究中,无 RA 的个体应描述为具有:RA 的遗传风险因素;RA 的环境风险因素;与 RA 相关的系统性自身免疫;无临床关节炎的症状;未分类关节炎;这些术语可以以组合的方式使用。建议在使用上述五个点中的任何一个或任何组合之前,可以在“pre-RA with:”前使用前缀,但只能在知道个体已经患有 RA 后,才能回顾性地描述个体已经经历过的阶段。建议采用一种疾病发病日期的方法。此外,还提出了重要的研究领域,包括研究可能引发适应性免疫反应的其他组织,以及确定 RA 发病、进展和关节外特征发展的其他风险因素和生物标志物。这些建议为描述 RA 发生前的阶段提供了指导,有助于研究人员之间的沟通和研究之间的比较。已经确定了一些研究问题,需要建立新的队列并开发新的技术,以便从不同部位进行成像和收集材料。